Pentamidine oral
Alternative Names: Oral OCZ103; VLX 103Latest Information Update: 26 Apr 2023
At a glance
- Originator Oncozyme Pharma
- Developer Odan Laboratories
- Class Antifungals; Antineoplastics; Antiprotozoals; Benzamidines; Sulfonic acids
- Mechanism of Action Endoexonuclease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alcoholic hepatitis; Liver cancer; Non-alcoholic steatohepatitis
Most Recent Events
- 26 Apr 2023 Discontinued - Phase-I for Liver cancer in Canada (PO) before April 2023 (Verlyx website, April 2023)
- 26 Apr 2023 Discontinued - Preclinical for Alcoholic hepatitis in Canada (PO) before April 2023 (Verlyx website, April 2023)
- 26 Apr 2023 Discontinued - Preclinical for Non-alcoholic steatohepatitis in Canada (PO) before April 2023 (Verlyx website, April 2023)